House convenes hearing on neuroscience research and military populations

The hearing highlighted the need for better assessment and treatment of disorders like traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD)
At the end of September, Dennis Kucinich (D-OH), Chairman of the House Oversight and Government Reform’s Subcommittee on Domestic Policy, held a hearing on Capitol Hill called “From Molecules to Minds: The Future of Neuroscience Research and Development.” Subcommittee member Rep. Patrick Kennedy (D-RI) also was instrumental in pushing for the hearing, designed to highlight the need for better assessment and treatment of neurologic and mental disorders, including traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD).  Kennedy and Kucinich were particularly concerned about how current research can address the needs of military personnel and veterans from the wars in Iraq and Afghanistan. The panel of federal witnesses included Tom Insel, MD (Director of the National Institute of Mental Health); Walter Koroshetz, MD (Deputy Director of the National Institute of Neurological Disease and Stroke); Joel Kupersmith, MD (Director of Research and Development, Department of Veterans Affairs); and psychologist Terry Rauch, PhD (Director of the Department of Defense Medical Research and Development Program). Panelists focused on areas of current research collaboration among federal agencies; their testimony may be found on the hearing website.